| Falwell Family Medicine, Pa | |
|
2201 Harrison St Batesville AR 72501-7418 | |
| (870) 307-0264 | |
| (870) 307-0382 |
| Full Name | Falwell Family Medicine, Pa |
|---|---|
| Speciality | Family Medicine |
| Location | 2201 Harrison St, Batesville, Arkansas |
| Authorized Official Name and Position | Kevin Wade Falwell (OWNER) |
| Authorized Official Contact | 8703070264 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Falwell Family Medicine, Pa 2201 Harrison St Batesville AR 72501-7418 Ph: (870) 307-0264 | Falwell Family Medicine, Pa 2201 Harrison St Batesville AR 72501-7418 Ph: (870) 307-0264 |
| NPI Number | 1740593771 |
|---|---|
| Provider Enumeration Date | 07/19/2010 |
| Last Update Date | 10/19/2011 |
| Medicare PECOS PAC ID | 5991990715 |
|---|---|
| Medicare Enrollment ID | O20101105001081 |
News Archive
Vitamin D deficiency has been implicated in numerous health conditions in recent years, including depressed mood and major depressive disorder.
For nearly 100 years, scientists have been trying to name cells. They have been describing them in the same way that Darwin described animals and trees. Now the Blue Brain Project has developed a mathematical algorithm to objectively classify the shapes of the neurons in the brain.
Advanced non-small cell lung cancer (NSCLC) patients have few effective treatment options and low 5-year survival rates. The checkpoint inhibitors MEDI4736 and tremelimumab have both demonstrated acceptable safety and potential efficacy when used as single-agents in several different types of cancer.
Orexigen Therapeutics, Inc. today announced that its 24-week, Phase 2b trial for Empatic(TM) (bupropion SR/zonisamide SR), the Company's second late stage investigational combination drug for the treatment of obesity, met its primary efficacy endpoint by demonstrating statistically significantly greater weight loss for both Empatic doses compared to monotherapies and placebo.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740593771 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | E4642 (Arkansas) | Primary |
| Provider Name | Kevin Wade Falwell |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1356373286 PECOS PAC ID: 4587667019 Enrollment ID: I20060822000589 |
News Archive
Vitamin D deficiency has been implicated in numerous health conditions in recent years, including depressed mood and major depressive disorder.
For nearly 100 years, scientists have been trying to name cells. They have been describing them in the same way that Darwin described animals and trees. Now the Blue Brain Project has developed a mathematical algorithm to objectively classify the shapes of the neurons in the brain.
Advanced non-small cell lung cancer (NSCLC) patients have few effective treatment options and low 5-year survival rates. The checkpoint inhibitors MEDI4736 and tremelimumab have both demonstrated acceptable safety and potential efficacy when used as single-agents in several different types of cancer.
Orexigen Therapeutics, Inc. today announced that its 24-week, Phase 2b trial for Empatic(TM) (bupropion SR/zonisamide SR), the Company's second late stage investigational combination drug for the treatment of obesity, met its primary efficacy endpoint by demonstrating statistically significantly greater weight loss for both Empatic doses compared to monotherapies and placebo.
› Verified 5 days ago
News Archive
Vitamin D deficiency has been implicated in numerous health conditions in recent years, including depressed mood and major depressive disorder.
For nearly 100 years, scientists have been trying to name cells. They have been describing them in the same way that Darwin described animals and trees. Now the Blue Brain Project has developed a mathematical algorithm to objectively classify the shapes of the neurons in the brain.
Advanced non-small cell lung cancer (NSCLC) patients have few effective treatment options and low 5-year survival rates. The checkpoint inhibitors MEDI4736 and tremelimumab have both demonstrated acceptable safety and potential efficacy when used as single-agents in several different types of cancer.
Orexigen Therapeutics, Inc. today announced that its 24-week, Phase 2b trial for Empatic(TM) (bupropion SR/zonisamide SR), the Company's second late stage investigational combination drug for the treatment of obesity, met its primary efficacy endpoint by demonstrating statistically significantly greater weight loss for both Empatic doses compared to monotherapies and placebo.
› Verified 5 days ago
Arcare Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2000 Harrison St Ste D, Batesville, AR 72501 Phone: 870-347-2534 | |
Jordan Weaver, M.d.,pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1995 Harrison St, Batesville, AR 72501 Phone: 870-793-2540 | |
Dennis Davidson Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2000 Harrison St, Suite D, Batesville, AR 72501 Phone: 870-793-4724 Fax: 870-793-4725 | |
Arcare 41 Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2450 Batesville Blvd, Batesville, AR 72501 Phone: 870-347-2534 | |
White River Health System, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2230 Harrison St, Batesville, AR 72501 Phone: 870-262-4444 | |
Wrmc Patient Care Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1710 Harrison St, Batesville, AR 72501 Phone: 870-262-6171 Fax: 870-262-6088 | |
White River Health Family Care Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1217 Batesville Blvd, Batesville, AR 72501 Phone: 870-262-2800 Fax: 870-262-2815 |